🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a phase I study of an agonistic CD40 antibody (mitazalimab) injecte...
Status
Recruiting
Location
UCSD Moores Cancer Center
Start Date
2024-07-17
Trial ID
NCT06205849
Treatments Being Tested
Irreversible electroporation (IRE) is a promising new ablation technique to...
Status
Completed
Location
Bart Geboers
Start Date
2016-05-30
Trial ID
NCT02791503
Treatments Being Tested
Irreversible electroporation is a non-thermal ablative technology that uses...
Status
Recruiting
Location
Tianjin Cancer Hospital Airport Hospital
Start Date
2026-04-01
Trial ID
NCT07795619
Treatments Being Tested
Pancreatic cancers is one the most important malignancies with highest mort...
Status
Completed
Location
Multiple Locations
Start Date
2012-11
Trial ID
NCT02841436
Treatments Being Tested
The aim of the study is the evaluation of the ablation efficiency of the pe...
Status
Unknown
Location
Department of Pathology University Hospital Otto-von-Guericke-University Magdeburg
Start Date
2013-10
Trial ID
NCT01967407
Treatments Being Tested
Liver cancer including primary hepatocellular carcinoma (HCC) and metastati...
Status
Completed
Location
National Taiwan University Hospital
Start Date
2012-11
Trial ID
NCT02828865
Treatments Being Tested
This is a single arm, phase II study without blinding. The purpose is to de...
Status
Active Not Recruiting
Location
Corewell Health West
Start Date
2019-02-05
Trial ID
NCT03856658
Treatments Being Tested
Following the results of study IMbrave150, the combination Atezolizumab + B...
Status
Active Not Recruiting
Location
CHU Amiens
Start Date
2021-02-23
Trial ID
NCT04727307
The purpose of this study is to evaluate the safety and efficacy of the Nan...
Status
Completed
Location
Hopital Beaujon
Start Date
2010-02
Trial ID
NCT01078415
Treatments Being Tested
Subjects will be offered the opportunity to participate in a randomized, co...
Status
Active Not Recruiting
Location
Miami Cancer Institute
Start Date
2021-02-23
Trial ID
NCT03899636
Treatments Being Tested